GSK, Teva Can't Put Brakes On Pay-For-Delay Challenge

Law360, New York (October 24, 2012, 4:42 PM EDT) -- GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd. on Tuesday failed to pause class action allegations that they conspired to keep a generic drug off the market, after a New Jersey federal judge said the U.S. Supreme Court wasn't likely to pick up a similar case potentially affecting the instant suit.

U.S. District Judge William H. Walls denied the pharmaceutical companies' bid to stay a case in which GSK and Teva face allegations they reached a "pay-for-delay" settlement preventing the release of a generic version of GSK's...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.